Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal penis morphology (HP:0000036)help
Parent Node:
expand
Abnormal male reproductive system physiology (HP:0012874)help
Parent Node:
expand
Erectile dysfunction (HP:0100639)help
..Starting node
..expand
Impotence (HP:0000802)help
Term ID: 802
Name: Impotence
Synonym: Difficulty getting a full erection; Difficulty getting an erection
Definition: Inability to develop or maintain an erection of the penis.
Comments:
Reference: HP:0000802
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandPriapism (HP:0200023) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0000802HP:0000802Impotence0ABCD1 CL E G H21561OMIM:300100Adrenoleukodystrophy135
HP:0000802HP:0000802Impotence0AIP CL E G H9049358ORPHA:963AcromegalyHP:0040283 - Occasional95
HP:0000802HP:0000802Impotence0AIP CL E G H9049358ORPHA:2965ProlactinomaHP:0040281 - Very frequent95
HP:0000802HP:0000802Impotence0AKT1 CL E G H207391ORPHA:2495MeningiomaHP:0040282 - Frequent54
HP:0000802HP:0000802Impotence0ATXN8 CL E G H72406632925ORPHA:98760Spinocerebellar ataxia type 8HP:0040282 - Frequent1
HP:0000802HP:0000802Impotence0ATXN8OS CL E G H631510561ORPHA:98760Spinocerebellar ataxia type 8HP:0040282 - Frequent1
HP:0000802HP:0000802Impotence0BAP1 CL E G H8314950ORPHA:2495MeningiomaHP:0040282 - Frequent184
HP:0000802HP:0000802Impotence0BMP2 CL E G H6501069OMIM:235200Hemochromatosis, type 1.13
HP:0000802HP:0000802Impotence0CACNA1G CL E G H89131394ORPHA:458803Spinocerebellar ataxia type 42HP:0040283 - Occasional32
HP:0000802HP:0000802Impotence0CDH23 CL E G H6407213733ORPHA:2965ProlactinomaHP:0040281 - Very frequent636
HP:0000802HP:0000802Impotence0CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenomaHP:0040282 - Frequent636
HP:0000802HP:0000802Impotence0CDKN1A CL E G H10261784ORPHA:652Multiple endocrine neoplasia type 1HP:0040282 - Frequent2
HP:0000802HP:0000802Impotence0CDKN1B CL E G H10271785ORPHA:652Multiple endocrine neoplasia type 1HP:0040282 - Frequent102
HP:0000802HP:0000802Impotence0CDKN2B CL E G H10301788ORPHA:652Multiple endocrine neoplasia type 1HP:0040282 - Frequent1
HP:0000802HP:0000802Impotence0CDKN2C CL E G H10311789ORPHA:652Multiple endocrine neoplasia type 1HP:0040282 - Frequent
HP:0000802HP:0000802Impotence0CHD7 CL E G H5563620626ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent515
HP:0000802HP:0000802Impotence0COQ2 CL E G H2723525223OMIM:146500Multiple system atrophy 1, susceptibility to.54
HP:0000802HP:0000802Impotence0DUSP6 CL E G H18483072ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent4
HP:0000802HP:0000802Impotence0FGF17 CL E G H88223673ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent3
HP:0000802HP:0000802Impotence0FGF8 CL E G H22533686ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent17
HP:0000802HP:0000802Impotence0FGFR1 CL E G H22603688ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent172
HP:0000802HP:0000802Impotence0FMR1 CL E G H23323775OMIM:300623Fragile X tremor/ataxia syndrome30
HP:0000802HP:0000802Impotence0FMR1 CL E G H23323775ORPHA:93256Fragile X-associated tremor/ataxia syndromeHP:0040282 - Frequent30
HP:0000802HP:0000802Impotence0GNRH1 CL E G H27964419ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent15
HP:0000802HP:0000802Impotence0GNRHR CL E G H27984421ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent92
HP:0000802HP:0000802Impotence0GPR101 CL E G H8355014963ORPHA:963AcromegalyHP:0040283 - Occasional5
HP:0000802HP:0000802Impotence0GUCY1A1 CL E G H29824685OMIM:615750Moyamoya disease 6 with achalasia.
HP:0000802HP:0000802Impotence0HAMP CL E G H5781715598ORPHA:79230Hemochromatosis type 2HP:0040282 - Frequent15
HP:0000802HP:0000802Impotence0HEXB CL E G H30744879OMIM:268800Sandhoff disease.80
HP:0000802HP:0000802Impotence0HFE CL E G H30774886OMIM:235200Hemochromatosis, type 1.38
HP:0000802HP:0000802Impotence0HJV CL E G H1487384887ORPHA:79230Hemochromatosis type 2HP:0040282 - Frequent
HP:0000802HP:0000802Impotence0HS6ST1 CL E G H93945201ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent8
HP:0000802HP:0000802Impotence0KISS1 CL E G H38146341ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent3
HP:0000802HP:0000802Impotence0KISS1R CL E G H846344510ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent14
HP:0000802HP:0000802Impotence0LMNB1 CL E G H40016637ORPHA:99027Adult-onset autosomal dominant leukodystrophyHP:0040283 - Occasional44
HP:0000802HP:0000802Impotence0LMNB1 CL E G H40016637OMIM:169500Leukodystrophy, adult-onset, autosomal dominant44
HP:0000802HP:0000802Impotence0MEN1 CL E G H42217010ORPHA:652Multiple endocrine neoplasia type 1HP:0040282 - Frequent462
HP:0000802HP:0000802Impotence0MEN1 CL E G H42217010ORPHA:2965ProlactinomaHP:0040281 - Very frequent462
HP:0000802HP:0000802Impotence0NF2 CL E G H47717773ORPHA:2495MeningiomaHP:0040282 - Frequent220
HP:0000802HP:0000802Impotence0NSMF CL E G H2601229843ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent6
HP:0000802HP:0000802Impotence0PDGFB CL E G H51558800ORPHA:2495MeningiomaHP:0040282 - Frequent9
HP:0000802HP:0000802Impotence0PIGA CL E G H52778957ORPHA:447Paroxysmal nocturnal hemoglobinuriaHP:0040283 - Occasional46
HP:0000802HP:0000802Impotence0PIK3CA CL E G H52908975ORPHA:2495MeningiomaHP:0040282 - Frequent162
HP:0000802HP:0000802Impotence0PROK2 CL E G H6067518455ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent9
HP:0000802HP:0000802Impotence0PROKR2 CL E G H12867415836ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent34
HP:0000802HP:0000802Impotence0SACS CL E G H2627810519ORPHA:98Autosomal recessive spastic ataxia of Charlevoix-SaguenayHP:0040284 - Very rare309
HP:0000802HP:0000802Impotence0SLC40A1 CL E G H3006110909OMIM:606069Hemochromatosis, type 4.56
HP:0000802HP:0000802Impotence0SMARCB1 CL E G H659811103ORPHA:2495MeningiomaHP:0040282 - Frequent87
HP:0000802HP:0000802Impotence0SMARCE1 CL E G H660511109ORPHA:2495MeningiomaHP:0040282 - Frequent47
HP:0000802HP:0000802Impotence0SMO CL E G H660811119ORPHA:2495MeningiomaHP:0040282 - Frequent22
HP:0000802HP:0000802Impotence0SPRY4 CL E G H8184815533ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent5
HP:0000802HP:0000802Impotence0SUFU CL E G H5168416466ORPHA:2495MeningiomaHP:0040282 - Frequent124
HP:0000802HP:0000802Impotence0TAC3 CL E G H686611521ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent6
HP:0000802HP:0000802Impotence0TACR3 CL E G H687011528ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent34
HP:0000802HP:0000802Impotence0TERT CL E G H701511730ORPHA:2495MeningiomaHP:0040282 - Frequent238
HP:0000802HP:0000802Impotence0TFR2 CL E G H703611762OMIM:604250Hemochromatosis, type 3.67
HP:0000802HP:0000802Impotence0TRAF7 CL E G H8423120456ORPHA:2495MeningiomaHP:0040282 - Frequent
HP:0000802HP:0000802Impotence0TTR CL E G H727612405OMIM:105210Amyloidosis, hereditary, transthyretin-related.107
HP:0000802HP:0000802Impotence0TTR CL E G H727612405ORPHA:85447ATTRV30M amyloidosisHP:0040282 - Frequent107
HP:0000802HP:0000802Impotence0WDR11 CL E G H5571713831ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent10


Genes (54) :ABCD1 AIP AKT1 ATXN8 ATXN8OS BAP1 BMP2 CACNA1G CDH23 CDKN1A CDKN1B CDKN2B CDKN2C CHD7 COQ2 DUSP6 FGF17 FGF8 FGFR1 FMR1 GNRH1 GNRHR GPR101 GUCY1A1 HAMP HEXB HFE HJV HS6ST1 KISS1 KISS1R LMNB1 MEN1 NF2 NSMF PDGFB PIGA PIK3CA PROK2 PROKR2 SACS SLC40A1 SMARCB1 SMARCE1 SMO SPRY4 SUFU TAC3 TACR3 TERT TFR2 TRAF7 TTR WDR11

Diseases (24) :OMIM:300100 ORPHA:963 ORPHA:2965 ORPHA:2495 ORPHA:98760 OMIM:235200 ORPHA:458803 ORPHA:91347 ORPHA:652 ORPHA:432 OMIM:146500 OMIM:300623 ORPHA:93256 OMIM:615750 ORPHA:79230 OMIM:268800 ORPHA:99027 OMIM:169500 ORPHA:447 ORPHA:98 OMIM:606069 OMIM:604250 OMIM:105210 ORPHA:85447
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.